DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II)

计划入组 600 人 · 首次发布于 2005 年 9 月 16 日

Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study

计划入组 98 人 · 首次发布于 2008 年 12 月 9 日

Aortic Valve-sparing Root Replacement, According to the Inclusion Technique Described by Tirone David

计划入组 529 人 · 首次发布于 2022 年 8 月 25 日

apoE4 structure correctors (Numerate/J David Gladstone Institutes)

CD40L-augmented Tumor Infiltrating Lymphocytes (H Lee Moffitt Cancer Center & Research Institute)

Globo H ADC(Development Center for Biotechnology)

H LEE MOFFITT CANCER CENTER

United States

ROBERT KOCH INSTITUTE

Sweden

RALPH H. JOHNSON VA MEDICAL CENTER

United States

Delayed Treatment May Improve Outcomes for Older DLBCL Patients, Study Suggests

Pioneer in Genitourinary Oncology: Dr. Christopher Logothetis's Journey from Greece to Revolutionizing Cancer Care

UNC Lineberger Cancer Center Leads $28 Million ARPA-H Trial to Revolutionize Metastatic Breast Cancer Treatment